• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4657932)   Today's Articles (3956)   Subscriber (51244)
For: Elkaeed EB, Salam HAAE, Sabt A, Al-Ansary GH, Eldehna WM. Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules. Molecules 2021;26:7611. [PMID: 34946704 PMCID: PMC8709016 DOI: 10.3390/molecules26247611] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 12/10/2021] [Accepted: 12/10/2021] [Indexed: 11/17/2022]  Open
Number Cited by Other Article(s)
1
Preeti, Raza A, Sharma RK, Sharma AK, Kumar V. Design, Synthesis, Anti-Proliferative, and Apoptotic Assessment of Spirocyclopropyl Oxindole-Isatin Hybrids on Triple-Negative Breast Cancer. Chem Biodivers 2024:e202402910. [PMID: 39654151 DOI: 10.1002/cbdv.202402910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2024] [Revised: 12/09/2024] [Accepted: 12/09/2024] [Indexed: 12/19/2024]
2
Anjomshoa M, Amirheidari B, Janczak J, Sahihi M, Abolhassani Y, Farsinejad A, Forootanfar H. In vitro and in silico studies of a Zn(II) complex as a potential therapeutic agent for breast cancer. Sci Rep 2024;14:29138. [PMID: 39587128 PMCID: PMC11589879 DOI: 10.1038/s41598-024-79644-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2024] [Accepted: 11/11/2024] [Indexed: 11/27/2024]  Open
3
Golcienė B, Vaickelionienė R, Endriulaitytė U, Mickevičius V, Petrikaitė V. Synthesis and effect of 4-acetylphenylamine-based imidazole derivatives on migration and growth of 3D cultures of breast, prostate and brain cancer cells. Sci Rep 2024;14:28065. [PMID: 39543257 PMCID: PMC11564686 DOI: 10.1038/s41598-024-76533-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2024] [Accepted: 10/15/2024] [Indexed: 11/17/2024]  Open
4
Singh G, Al-Fahad D, Al-Zrkani MK, Chaudhuri TK, Soni H, Tandon S, Narasimhaji CV, Azam F, Patil R. Identification of potential inhibitors of HER2 targeting breast cancer-a structure-based drug design approach. J Biomol Struct Dyn 2024;42:8184-8201. [PMID: 37565730 DOI: 10.1080/07391102.2023.2246576] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Accepted: 07/27/2023] [Indexed: 08/12/2023]
5
Volkova Y, Scherbakov A, Dzichenka Y, Komkov A, Bogdanov F, Salnikova D, Dmitrenok A, Sachanka A, Sorokin D, Zavarzin I. Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells. RSC Med Chem 2024;15:2380-2399. [PMID: 39026643 PMCID: PMC11253874 DOI: 10.1039/d4md00153b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Accepted: 05/30/2024] [Indexed: 07/20/2024]  Open
6
Ossowicz-Rupniewska P, Klebeko J, Georgieva I, Apostolova S, Struk Ł, Todinova S, Tzoneva RD, Guncheva M. Tuning of the Anti-Breast Cancer Activity of Betulinic Acid via Its Conversion to Ionic Liquids. Pharmaceutics 2024;16:496. [PMID: 38675157 PMCID: PMC11053683 DOI: 10.3390/pharmaceutics16040496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Revised: 03/14/2024] [Accepted: 03/28/2024] [Indexed: 04/28/2024]  Open
7
Stefaniak-Napieralska M, Walczyński K, Iwan M, Korga-Plewko A, Szałaj N, Więckowska A, Staszewski M. Preliminary studies of 1,5-benzoxazepine derivatives as potential histamine H3 receptor antagonists. Future Med Chem 2024;16:197-204. [PMID: 38189171 DOI: 10.4155/fmc-2023-0277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Accepted: 12/21/2023] [Indexed: 01/09/2024]  Open
8
Abd El Salam HA, Fathy U, Zayed EM, El Shehry MF, Ahmed E.Gouda A. Design, Synthesis, Cytotoxic Activity and Molecular Docking Studies of Naphthyl Pyrazolyl Thiazole Derivatives as Anticancer Agents. ChemistrySelect 2023. [DOI: 10.1002/slct.202203956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
9
2-{5-[(Z,2Z)-2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-oxo-2-thioxothiazolidin-3-yl}-3-methylbutanoic Acid as a Potential Anti-Breast Cancer Molecule. Int J Mol Sci 2022;23:ijms23084091. [PMID: 35456915 PMCID: PMC9032233 DOI: 10.3390/ijms23084091] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Revised: 04/02/2022] [Accepted: 04/05/2022] [Indexed: 01/27/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA